← Evidence map

ArticleNature2018

Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.

Loren M Lasko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29769713